DESCRIPTION (provided by applicant): The overall objective of this research is to test the hypothesis that monoclonal antibodies to radiation-induced tumor neoantigens cause therapeutically beneficial ...SBIR Phase I 2012 Department of Health and Human Services
RADTARGX THERAPEUTICS, INC.
| 4041 FOREST PARK AVE
SAINT LOUIS, MO, 63108-3213
|Socially and Economically Disadvantaged:||N|
|Number of Employees:||n/a|